dual glp 1 and gip receptor agonist examples The glucose-dependent insulinotropic polypeptide (GIP) glucagon-like peptide-1 (GLP-1) tirzepatide: a novel cardiometabolic therapeutic prospect | Cardiovascular Diabetology Frontiers | Clinical perspectives on
Description
Searching for the most effective weight loss medication
Of note, SGLT2 inhibitors also reduce cardiovascular mortality or hospitalization for heart failure, thus showing benefits across the cardiorenal axis
doi: 10.2337/DC12-2462
GLP-1 , ()
